GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » Dividend-Payout-to-FFO

GH Research (STU:1KA) Dividend-Payout-to-FFO


View and export this data going back to 2024. Start your Free Trial

What is GH Research Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


GH Research Business Description

Comparable Companies
Traded in Other Exchanges
Address
Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.